Foley Partner, Edward Polk, Jr. will be speaking on September 16, 2010 at the Practicing Law Institute (PLI) – Developments in Pharmaceutical and Biotech Patent Law 2010. Mr. Polk will be discussing “Recent Changes in Patent Prosecution Practice”. His discussion will include the following points:
- Changes to the USPTO count system
- What are the implications of changes to the USPTO count system for biotech & pharma prosecutors?
- How could the changes impact RCE practice?
- Changes to BPAI appeal practice
- How will PTO's changes streamline BPAI appeal practice?
- How will changes impact appeals from TC 1600?
- Proposed changes to missing parts practice to allow for 12 month extension for provisional patent applications
- Do the proposed changes really provide a 12-month extension to the 12-month provisional application period?
- Can the proposed changes be used to extend patent term for pharmaceutical applications?
- In re Tanaka (BPAI)
- Is the addition of narrower claims a valid reason for filing a reissue if applicant does not also allege that one or more of the broader patent claims is overly broad?
- Can reissue applicant add specific species compound claims without also alleging broader genus claims are invalid?
For more information, please visit the Practicing Law Institute Web site.